Kumano N, Kikumoto T, Koinumaru S, Nakai Y, Ishikawa T, Suzuki S, Konno K
Tohoku J Exp Med. 1981 Aug;134(4):401-9. doi: 10.1620/tjem.134.401.
Prophylaxis of 3-methylcholanthrene-induced epithelial tumor formation in ddI mice with our Candida utilis glucomannan preparation (YPS) was confirmed further in the present system of fibrosarcoma production. A single subcutaneous dose of MCA (0.5 mg per mouse) was either preceded by or followed by 10 or 30 daily intraperitoneal (i.p.) injections of YPS at the dosage of 100 mg/kg per dose according to various time schedules. Protective effect of YPS was demonstrable by a significantly lengthened latent period before the tumor appearance and a slower rate of the subsequent tumor production until around day 100. All the schedules of pre- or post-treatment were found to be effective, although the one delayed until two weeks post MCA was so only marginally. It was also disclosed by prolonging the observation period that this protection was of a transient nature, 100 per cent tumor incidence being found by around 150 days post MCA in all the experimental groups. A longer latency due to the treatment with YPS was generally found in association with a faster growth of the tumor and a shorter life span of the host animal. Temporary protection of MCA-induced tumorigenesis in ddI mice was not reproducible in C3H/He mice, and was thus suggested the possible strain-dependent nature of YPS effect.
在当前的纤维肉瘤生成系统中,我们进一步证实了用产朊假丝酵母葡甘露聚糖制剂(YPS)预防ddI小鼠中3 - 甲基胆蒽诱导的上皮肿瘤形成。根据不同的时间安排,在单次皮下注射MCA(每只小鼠0.5毫克)之前或之后,每天腹腔注射10或30次YPS,剂量为每剂100毫克/千克。YPS的保护作用可通过肿瘤出现前潜伏期显著延长以及随后直到约第100天肿瘤产生速率减缓来证明。尽管延迟至MCA后两周的治疗方案仅有微弱效果,但所有预处理或后处理方案均被发现有效。通过延长观察期还发现,这种保护是短暂的,在MCA后约150天,所有实验组的肿瘤发生率均达到100%。一般发现,由于YPS治疗导致的较长潜伏期与肿瘤生长更快和宿主动物寿命较短相关。在C3H/He小鼠中无法重现YPS对ddI小鼠MCA诱导肿瘤发生的临时保护作用,因此提示YPS作用可能具有品系依赖性。